---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-004233"
form_type: "8-K"
ticker: "HURA"
cik: "0001498382"
company_name: "TuHURA Biosciences, Inc./NV"
filed_at: "2022-02-08T23:59:59+00:00"
generated_at: "2026-06-27T10:05:07.272237+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Kintara director Keith Murphy resigns from board effective Feb 4, 2022

## Summary
- Keith Murphy resigned from the Board of Directors, Compensation Committee, and Nominating and Corporate Governance Committee, effective February 4, 2022.
- Resignation was not due to any disagreements with the company regarding its operations, policies, or practices.
- No replacement for Murphy on the board or committees has been announced in this filing.

## SEC filing metadata
- accession: 0001564590-22-004233
- form_type: 8-K
- ticker: HURA
- cik: 0001498382
- company_name: TuHURA Biosciences, Inc./NV
- filed_at: 2022-02-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1498382/000156459022004233/0001564590-22-004233-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1498382/000156459022004233/ktra-8k_20220204.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-004233
- JSON: https://secwatch.observer/filing/0001564590-22-004233.json
- Plain text: https://secwatch.observer/filing/0001564590-22-004233.txt

## Key facts
- Executive change
  Keith Murphy resigned as Director at TuHURA Biosciences, Inc./NV.
  - Action: resigned
  - Role: Director
  source text: On February 4, 2022, Keith Murphy submitted his resignation from the Board of Directors (the “Board”) of Kintara Therapeutics, Inc. (the “Company”), effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1498382/000156459022004233/0001564590-22-004233-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.